• Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
Thursday, November 19, 2026
No Result
View All Result
Subscribe Now
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Trump’s Deal Turns Sour as Voters Withdraw Support

    Trump’s Deal Turns Sour as Voters Withdraw Support

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
The Insight Post
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    Trump’s Deal Turns Sour as Voters Withdraw Support

    Trump’s Deal Turns Sour as Voters Withdraw Support

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
No Result
View All Result
No Result
View All Result
Home Oceania Australia New Zealand

COVID-19 Summer Checklist: How Kiwis Can Embrace Their Holiday Season – Survey

by Theinsightpost
November 26, 2022
in New Zealand
0 0
0
COVID-19 Summer Checklist: How Kiwis Can Embrace Their Holiday Season – Survey


Tuesday, 22 November 2022, 10:25 am
Press Release: Pfizer

New research released by Pfizer today reveals that only
14% of New Zealanders feel that their life is back to normal
following the COVID-19 pandemic. With the nation planning
its summer in the midst of rising case numbers, Kiwis are
being encouraged to have a COVID-19 summer checklist so they
can enjoy their anticipated holiday season with family and
friends.

Pfizer New Zealand Medical Director, Krishan
Thiru, said that with COVID-19 cases once again rising, it
is important to plan ahead as we enter our third summer, and
third holiday season, living with the virus.

“We
want to ensure Kiwis enjoy a well-deserved break this
summer. While making holiday plans, taking a few simple
steps can help reduce COVID-19 spread and the risk of
serious illness and hospitalisation, and helps maximise
quality time with friends and family.”

Thiru
recommends Kiwis have a checklist to protect themselves,
their whānau and friends in the coming weeks, in addition
to the usual public health measures:

· Stay up to
date with vaccinations and boosters.

· Pack Rapid
Antigen Tests if you’re going away.

· Have a
four-step plan if you test positive:

1. Speak to your
pharmacist or GP to check if you are eligible for antiviral
treatments.

2. Learn about antiviral treatments
available at treatpositive.co.nz

3.
Find participating pharmacies nearest to you or your
destination at healthpoint.co.nz

4.
Phone your doctor or local pharmacy straight away if you
test positive for COVID-19.

The study was undertaken
by New Zealand research firm Talbot Mills, and sponsored by
Pfizer, with more than 1,300 Kiwis to help understand the
ongoing impact of COVID-19.

The research shows New
Zealanders are still afraid of contracting COVID-19, with
more than half (59%) of respondents saying they are fearful
of catching the virus, and nearly a third (30%) reporting
they are still constraining their activities. However, this
does not need to be the case.

The availability of
antiviral treatments, such as Pfizer’s PAXLOVID®
(nirmatrelvir tablets and ritonavir tablets) does seem to
help allay fears. More than half (52%) of respondents stated
they are “very” or “quite a lot” fearful of catching
the virus, indicating that having access to treatments like
PAXLOVID would make them feel more inclined to live their
life like they did pre-COVID.

PAXLOVID is fully funded
and now widely available for eligible New Zealanders at more
than 400 pharmacy locations nationwide, with free delivery
offered to patients’ homes if
required.

“Vaccination remains the first line of
defence against the virus. However, with one million New
Zealanders being eligible to treat their COVID-19 infection
with antiviral medication, we encourage Kiwis to find out if
they are eligible for treatments and how to access them as a
second line of defence before they need them,” Thiru
said.

Eligibility will depend on several factors,
including age, ethnicity, other health conditions and
vaccination status, so speak to your pharmacist or GP to
check if PAXLOVID is right for you.

For more details,
check
out Pharmac’s access criteria here
and visit: http://www.treatpositive.co.nz.
To check the nearest pharmacy that stocks Paxlovid visit: healthpoint.co.nz.

Notes
for the Editor:

Pharmac’s access criteria for
COVID-19 antivirals is available at: COVID-19
antivirals: Access Criteria – Pharmac | New Zealand
Government

At a COVID-19 briefing in September,
the New Zealand Government announced it had secured 100,000
treatment courses of PAXLOVID in 2022, making it available
to around one million Kiwis. This follows the initial supply
agreement signed in December 2021, and Medsafe’s
provisional consent for the supply and use of PAXLOVID in
New Zealand in March 2022.

*About Antivirals

A
COVID-19 antiviral treatment is a medicine that works by
slowing or stopping the virus from replicating. This may
help reduce symptoms and the risk of significant health
complications.

About the Research

Pfizer engaged
with Talbot Mills to undertake research into the ongoing
impact of the pandemic on the everday lives of New
Zealanders. The research was conducted through Talbot Mills
Research online daily tracking survey.

The survey
comprised of a sample that was nationally representative of
1,333 members of the general public aged 18 years and over.
The maximum margin of error (at 95% confidence) for a random
sample of n=1333 is +/- 2.7.

About PAXLOVID®
(nirmatrelvir tablets and ritonavir tablets)
PAXLOVID is
a SARS-CoV-2 main protease (Mpro) inhibitor (also known as
SARS-CoV-2 3CL protease inhibitor) therapy. It was developed
to be administered orally so that it can be prescribed early
after infection, potentially helping patients avoid severe
illness (which can lead to hospitalisation and death).
Nirmatrelvir [PF-07321332], which originated in Pfizer
laboratories, is designed to block the activity of the Mpro,
an enzyme that the coronavirus needs to replicate.
Co-administration with a low dose of ritonavir helps slow
the metabolism, or breakdown, of nirmatrelvir in order for
it to remain active in the body for longer periods of time
at higher concentrations to help combat the
virus.

Nirmatrelvir is designed to inhibit viral
replication at a stage known as proteolysis, which occurs
before viral RNA replication. In preclinical studies,
nirmatrelvir did not demonstrate evidence of mutagenic DNA
interactions.

Current variants of concern can be
resistant to treatments that work by binding to the spike
protein found on the surface of the SARS-CoV-2 virus.
PAXLOVID, however, works intracellularly by binding to the
highly conserved Mpro (3CL protease) of the SARS-CoV-2 virus
to inhibit viral replication. Nirmatrelvir has shown
consistent in vitro antiviral activity against the following
variants: Alpha, Beta, Delta, Gamma, Lambda, Mu, and Omicron
BA.1,BA.2 and BA.4.

PAXLOVID is generally administered
at a dose of 300 mg (two 150 mg tablets) of nirmatrelvir
with one 100 mg tablet of ritonavir, given twice-daily for
five days. One carton contains five blister packs
of

PAXLOVID, as co-packaged nirmatrelvir tablets with
ritonavir tablets, providing all required doses for a full
five-day treatment course.

PAXLOVID® is a registered
trademark.

About Pfizer: Breakthroughs That Change
Patients’ LivesTM

At Pfizer, we apply science and
our global resources to bring therapies to people that
extend and significantly improve their lives. We strive to
set the standard for quality, safety and value in the
discovery, development and manufacture of health care
products, including innovative medicines and vaccines. Every
day, Pfizer colleagues work across developed and emerging
markets to advance wellness, prevention, treatments and
cures that challenge the most feared diseases of our time.
Consistent with our responsibility as one of the world’s
premier innovative biopharmaceutical companies, we
collaborate with health care providers, governments and
local communities to support and expand access to reliable,
affordable health care around the world. For more than 170
years, we have worked to make a difference for all who rely
on us. For more information, please visit: www.pfizer.co.nz

© Scoop Media

Join Scoop Citizen

Scoop is a champion of independent journalism and open publishing – informing New Zealanders through straight-talking independent journalism, and publishing news from a wide range of sectors. Join us and support the publication of trustworthy, relevant, public interest news, freely accessible to all New Zealanders:

Become a member
Find out more

Find more from Pfizer on InfoPages.

 



Source link

ShareTweetSend
Previous Post

Australia news live: Anthony Albanese suggests censure of Scott Morrison ‘likely’ over secret ministries | Victoria

Next Post

Union urges Barbados Gov’t to pay Severance to ex-LIAT Workers

Related News

Anthropic Launches Historic IPO, Soaring to New Heights in Market Value
New Zealand

Anthropic Launches Historic IPO, Soaring to New Heights in Market Value

November 19, 2026
Authorities Respond to Firearms Incident in West Melton, Canterbury
New Zealand

Authorities Respond to Firearms Incident in West Melton, Canterbury

November 19, 2026
Are Media Experiences Remarkable Growth in Readership for Its Leading Magazine Titles
New Zealand

Are Media Experiences Remarkable Growth in Readership for Its Leading Magazine Titles

November 19, 2026
Police Recovery: Firearm and Drug Paraphernalia Discovered in Vehicle Following Driver’s Evasion Attempt
New Zealand

Police Recovery: Firearm and Drug Paraphernalia Discovered in Vehicle Following Driver’s Evasion Attempt

November 18, 2026
Next Post
Union urges Barbados Gov’t to pay Severance to ex-LIAT Workers

Union urges Barbados Gov’t to pay Severance to ex-LIAT Workers

Discussion about this post

Subscribe To Our Newsletters

    Customer Support


    1251 Wilcrest Drive
    Houston, Texas
    77042 USA
    Call-832.795.1420
    e-mail – news@theinsightpost.com

    Subscribe To Our Newsletters

      Categories

      • Africa
      • Africa-East
      • African Sports
      • American Sports
      • Arts
      • Asia
      • Australia
      • Business
      • Business Asia
      • Business- Africa
      • Canada
      • Defense
      • Education
      • Egypt
      • Energy
      • Entertainment
      • Europe
      • European Soccer
      • Finance
      • Germany
      • Ghana
      • Health
      • Insight
      • International
      • Investing
      • Japan
      • Latest Headlines
      • Life & Living
      • Markets
      • Mobile
      • Movies
      • New Zealand
      • Nigeria
      • Politics
      • Scholarships
      • Science
      • South Africa
      • South America
      • Sports
      • Tech
      • Travel
      • Travel-Africa
      • UK
      • USA
      • Weather
      • World
      No Result
      View All Result

      Recent News

      Putin Promises Consequences Following Ukraine’s Assault on Kerch Strait Bridge

      Putin Promises Consequences Following Ukraine’s Assault on Kerch Strait Bridge

      November 19, 2026
      Brian Blessed Shares Amusing Encounter with Female Gorillas at Zoo

      Brian Blessed Shares Amusing Encounter with Female Gorillas at Zoo

      November 19, 2026
      Unveiling the Real Narrative: ‘The Altruists’ and Their Connection to the FTX Controversy

      Unveiling the Real Narrative: ‘The Altruists’ and Their Connection to the FTX Controversy

      November 19, 2026
      Is Hakeem Jeffries Facing a Moment of Crisis?

      Is Hakeem Jeffries Facing a Moment of Crisis?

      November 19, 2026
      • Home
      • Advertise With Us
      • About Us
      • Corporate
      • Consumer Rewards
      • Forum
      • Privacy Policy
      • Social Trends

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      Welcome Back!

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In

      Add New Playlist

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in .

      No Result
      View All Result
      • Home
      • Insight
      • Blog
      • Business
      • Entertainment
      • Health
      • Politics
      • Shop
        • Gift Shop
        • Value Shop
        • Store
        • Bargain Shop
        • Discount
      • Sports
      • Tech
      • Travel
      • USA
      • Video
      • World
        • Asia
        • Africa
        • South America
        • North America
        • Europe
        • Oceania

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      The Insight Post
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      Cookie Policy

      More information about our Cookie Policy